TFEB and metabolic dysfunction-associated steatotic liver disease: Zhang et al. [72] confirmed that metformin attenuates hepatic steatosis and insulin resistance in mouse models of nonalcoholic fatty liver disease by enhancing TFEB-mediated autophagy.